Outpatient versus inpatient treatment in patients with pulmonary embolism: A meta-analysis

European Respiratory Journal

Volumn 42, Issue 1, 2013, Pages 134-144

  Zondag, Wendy ^a   Kooiman, Judith ^a   Klok, Frederikus A ^a   Dekkers, Olaf M ^a   Huisman, Menno V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE DISEASE; ADULT; ADVERSE OUTCOME; ARTICLE; BLEEDING DISORDER; CAUSE OF DEATH; CLINICAL EVALUATION; DRUG EFFECT; DRUG SAFETY; FEMALE; HOME CARE; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; LOW RISK POPULATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OUTPATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; HEMORRHAGE; HUMANS; INPATIENTS; OUTPATIENTS; PATIENT DISCHARGE; PULMONARY EMBOLISM; PULMONARY MEDICINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84880165502     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00093712     Document Type: Article

References (34)

1. Aujesky D, Stone RA, Kim S, et al. Length of hospital stay and postdischarge mortality in patients with pulmonary embolism: a statewide perspective. Arch Intern Med 2008; 168: 706-712. (Pubitemid 351563953)
2. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e419S-e494S.
3. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29: 2276-2315.
4. Agterof MJ, Schutgens RE, Snijder RJ, et al. Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level. J Thromb Haemost 2010; 8: 1235-1241.
5. Aujesky D, Roy PM, Verschuren F, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 2011; 378: 41-48.
6. Erkens PM, Gandara E, Wells P, et al. Safety of outpatient treatment in acute pulmonary embolism. J Thromb Haemost 2010; 8: 2412-2417.
7. Kovacs MJ, Hawel JD, Rekman JF, et al. Ambulatory management of pulmonary embolism: a pragmatic evaluation. J Thromb Haemost 2010; 8: 2406-2411.
8. Zondag W, Mos IC, Creemers-Schild D, et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 2011; 9: 1500-1507.
9. Carrier M, Le Gal G, Wells PS, et al. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med 2010; 152: 578-589.
10. Nieto JA, Solano R, Ruiz-Ribo MD, et al. Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry. J Thromb Haemost 2010; 8: 1216-1222.
11. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med 2010; 363: 266-274.
12. Janjua M, Badshah A, Matta F, et al. Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review. Thromb Haemost 2008; 100: 756-761.
13. Squizzato A, Galli M, Dentali F, et al. Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review. Eur Respir J 2009; 33: 1148-1155.
14. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions, version 5.0.1. 2008. The Cochrane Collaboration. www.cochrane.org/training/cochrane-handbook Date last updated: September 2008. Date last accessed: February 11, 2013.
15. Hamza TH, van Houwelingen HC, Stijnen T. The binomial distribution of meta-analysis was preferred to model within-study variability. J Clin Epidemiol 2008; 61: 41-51. (Pubitemid 350236698)
16. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172: 1041-1046. (Pubitemid 41476544)
17. Hutten BA, Prins MH, Gent M, et al. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 2000; 18: 3078-3083.
18. Buller HR, Davidson BL, Decousus H, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 349: 1695-1702. (Pubitemid 37315006)
19. van Belle A, Buller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006; 295: 172-179. (Pubitemid 43076436)
20. Beer JH, Burger M, Gretener S, et al. Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients. J Thromb Haemost 2003; 1: 186-187.
21. Davies CW, Wimperis J, Green ES, et al. Early discharge of patients with pulmonary embolism: a two-phase observational study. Eur Respir J 2007; 30: 708-714. (Pubitemid 351194831)
22. Kovacs MJ, Anderson D, Morrow B, et al. Outpatient treatment of pulmonary embolism with dalteparin. Thromb Haemost 2000; 83: 209-211. (Pubitemid 30093220)
23. Lui B, Tran A, Montalto M. Treatment of patients with pulmonary embolism entirely in Hospital in the Home. Aust Fam Physician 2007; 36: 381-384.
24. Olsson CG, Bitzen U, Olsson B, et al. Outpatient tinzaparin therapy in pulmonary embolism quantified with ventilation/perfusion scintigraphy. Med Sci Monit 2006; 12: P19-P13.
25. Ong BS, Karr MA, Chan DK, et al. Management of pulmonary embolism in the home. Med J Aust 2005; 183: 239-242. (Pubitemid 41245942)
26. Otero R, Uresandi F, Jimenez D, et al. Home treatment in pulmonary embolism. Thromb Res 2010; 126: e1-e5.
27. Rodriguez-Cerrillo M, Alvarez-Arcaya A, Fernandez-Diaz E, et al. A prospective study of the management of nonmassive pulmonary embolism in the home. Eur J Intern Med 2009; 20: 598-600.
28. Siragusa S, Arcara C, Malato A, et al. Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients. Ann Oncol 2005; 16: Suppl. 4, iv136-iv139. (Pubitemid 43084961)
29. Wells PS, Anderson DR, Rodger MA, et al. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. Arch Intern Med 2005; 165: 733-738. (Pubitemid 40569425)
30. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-694. (Pubitemid 41647882)
31. Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 677-681. (Pubitemid 26079800)
32. Lankeit M, Konstantinides S. Is it time for home treatment of pulmonary embolism?Eur Respir J 2012; 40: 742-749.
33. Aujesky D, Perrier A, Roy PM, et al. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med 2007; 261: 597-604. (Pubitemid 46835983)
34. Wicki J, Perrier A, Perneger TV, et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000; 84: 548-552.